MPD: Measures involving DO population

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Attie2:1	Attie2	None	(none)	JMUS id JMUSid 110618 categorical informational	DO population		both		N=242	2018

Attie2:2	Attie2	None	(none)	diet diet 110619 categorical informational	DO population		both		N=250	2018

Attie2:3	Attie2	None	(none)	DO generation DO_generation 110620 informational	DO population		both		N=250	2018

Attie2:4	Attie2	None	(none)	DO batch1 DO_batch1 110621 informational	DO population		both		N=250	2018

Attie2:5	Attie2	None	(none)	DO batch2 DO_batch2 110622 informational	DO population		both		N=250	2018

Attie2:6	Attie2	None	(none)	DO batch3 DO_batch3 110623 informational	DO population		both		N=250	2018

Attie2:7	Attie2	None	(none)	DO batch4 DO_batch4 110624 informational	DO population		both		N=250	2018

Attie2:8	Attie2	None	(none)	DO batch5 DO_batch5 110625 informational	DO population		both		N=250	2018

Attie2:9	Attie2	None	(none)	date of birth DOB 110626 categorical informational	DO population		both		N=242	2018

Attie2:10	Attie2	None	(none)	date of death DOD 110627 categorical informational	DO population		both		N=194	2018

Attie2:11	Attie2	None	(none)	date of oral glucose tolerance test date_oGTT 110628 categorical informational	DO population		both		N=248	2018

Attie2:12	Attie2	None	(none)	coat color coat_color 110629 categorical informational	DO population		both		N=250	2018

Attie2:13	Attie2	None	(none)	some mice store food in bedding which would incorrectly be interpreted as consumed crumblers 110630 categorical informational	DO population		both		N=8	2018

Attie2:14	Attie2	colony observation	high-fat high-sucrose diet	number of days on diet [n] diet_days 110631	DO population		both	4-26wks	N=242	2018

Attie2:15	Attie2	body weight	high-fat high-sucrose diet	body weight after diet [g] bw 110632 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (5 more)...	DO population		both	5-26wks	N=250	2018

Attie2:37	Attie2	body weight	high-fat high-sucrose diet	change in body weight after diet (compared to wk 1) [g] bw_chg 110654 wk: 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17	DO population		both	6-21wks	N=250	2018

Attie2:53	Attie2	body weight	high-fat high-sucrose diet	change in body weight after diet (compared to wk 10), wk 17 [g] bw_chg_wk17v10 110670	DO population		both	21wks	N=236	2018

Attie2:54	Attie2	intake monitoring	high-fat high-sucrose diet	food consumption after diet [g] food 110671 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (4 more)...	DO population		both	5-25wks	N=250	2018

Attie2:75	Attie2	intake monitoring	high-fat high-sucrose diet	food consumption average after diet (1 to 21 wks) [g] food_ave 110692	DO population		both	5-25wks	N=250	2018

Attie2:76	Attie2	metabolic panel	high-fat high-sucrose diet	plasma glucose after diet (4h fast) [mg/dL] GLU 110693 wk: 6 10 14 22	DO population		both	10-26wks	N=250	2018

Attie2:80	Attie2	hormone quantification	high-fat high-sucrose diet	plasma insulin after diet (4h fast) [ng/mL] INS 110697 wk: 6 10 14 22	DO population		both	10-26wks	N=250	2018

Attie2:84	Attie2	lipid profile	high-fat high-sucrose diet	plasma triglyceride after diet (4h fast) [mg/dL] TG 110701 wk: 6 10 14 22	DO population		both	10-26wks	N=250	2018

Attie2:88	Attie2	body weight	high-fat high-sucrose diet	body weight at time of oral glucose tolerance test (~14 wks on diet) [g] bw_oGTT 110705	DO population		both	18wks	N=248	2018

Attie2:89	Attie2	glucose tolerance	high-fat high-sucrose diet	glucose level at t=0 after ~14 wks on diet (4h fast) [mg/dL] GLU_0min 110706	DO population		both	18wks	N=248	2018

Attie2:90	Attie2	glucose tolerance	high-fat high-sucrose diet	insulin level at t=0 after ~14 wks on diet (4h fast) [ng/mL] INS_0min 110707	DO population		both	18wks	N=248	2018

Attie2:91	Attie2	glucose tolerance	high-fat high-sucrose diet	HOMA-IR: (glucose x insulin) / 405 at t=0 after ~14 wks on diet (4h fast) HOMA_IR 110708	DO population		both	18wks	N=248	2018

Attie2:92	Attie2	glucose tolerance	high-fat high-sucrose diet	HOMA-B: (360 x insulin) / (glucose minus 63) at t=0 after ~14 wks on diet (4h fast) HOMA_B 110709	DO population		both	18wks	N=246	2018

Attie2:93	Attie2	glucose tolerance	high-fat high-sucrose diet	glucose area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] GLU_AUC_tot 110710	DO population		both	18wks	N=248	2018

Attie2:94	Attie2	glucose tolerance	high-fat high-sucrose diet	glucose area under curve (AUC) after ~14 wks on diet after subtraction of glucose at t=0 (4h fast) [AUC] GLU_AUC_adj 110711	DO population		both	18wks	N=248	2018

Attie2:95	Attie2	glucose tolerance	high-fat high-sucrose diet	insulin area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] INS_AUC_tot 110712	DO population		both	18wks	N=248	2018

Attie2:96	Attie2	glucose tolerance	high-fat high-sucrose diet	insulin area under curve (AUC) after ~14 wks on diet after subtraction of insulin at t=0 (4h fast) [AUC] INS_AUC_adj 110713	DO population		both	18wks	N=248	2018

Attie2:97	Attie2	hormone quantification	high-fat high-sucrose diet	plasma adiponectin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [µg/mL] adiponectin 110714	DO population		both	18wks	N=144	2018

Attie2:98	Attie2	hormone quantification	high-fat high-sucrose diet	plasma leptin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [ng/mL] leptin 110715	DO population		both	18wks	N=96	2018

Attie2:99	Attie2	microscopy	high-fat high-sucrose diet	number of islets harvested per mouse after diet [n] islets 110716	DO population		both	19-26wks	N=242	2018

Attie2:100	Attie2	hormone quantification	high-fat high-sucrose diet	amount of insulin per islet after diet [ng/mL] INS_per_islet 110717	DO population		both	19-26wks	N=241	2018

Attie2:101	Attie2	hormone quantification	high-fat high-sucrose diet	whole pancreas insulin content after diet (insulin content per islet times number of islets) [ng/mL] INS_per_pancreas 110718	DO population		both	19-26wks	N=241	2018

Attie2:102	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose [ng/mL] INS_GLU 110719 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=242	2018

Attie2:105	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] INS_GLU3p3_KCl 110722	DO population		both	19-26wks	N=240	2018

Attie2:106	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 [ng/mL] INS_GLU8p3_GLP1 110723	DO population		both	19-26wks	N=240	2018

Attie2:107	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) [ng/mL] INS_GLU8p3_AA 110724	DO population		both	19-26wks	N=240	2018

Attie2:108	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid [ng/mL] INS_GLU16p7_PA 110725	DO population		both	19-26wks	N=240	2018

Attie2:109	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_fc_G3p3 110726	DO population		both	19-26wks	N=240	2018

Attie2:110	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose, expressed as fold-change over that observed with 3.3.mM glucose [ratio] INS_GLU16p7_fc_G3p3 110727	DO population		both	19-26wks	N=240	2018

Attie2:111	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU3p3__KCl_fc_G3p3 110728	DO population		both	19-26wks	N=240	2018

Attie2:112	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G3p3 110729	DO population		both	19-26wks	N=240	2018

Attie2:113	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G3p3 110730	DO population		both	19-26wks	N=240	2018

Attie2:114	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus palmitic acid, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU16p7_PA_fc_G3p3 110731	DO population		both	19-26wks	N=240	2018

Attie2:115	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G8p3 110732	DO population		both	19-26wks	N=240	2018

Attie2:116	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G8p3 110733	DO population		both	19-26wks	N=240	2018

Attie2:117	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as fold-change over that observed with 16.7 mM glucose [ratio] INS_GLU16p7_PA_fc_G16p7 110734	DO population		both	19-26wks	N=240	2018

Attie2:118	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose, expressed as a percentage of total insulin per mouse [%] INS_pct_GLU 110735 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=241	2018

Attie2:121	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total insulin per mouse [%] INS_GLU3p3_KCl_pct 110738	DO population		both	19-26wks	N=239	2018

Attie2:122	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_GLP1_pct 110739	DO population		both	19-26wks	N=239	2018

Attie2:123	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_AA_pct 110740	DO population		both	19-26wks	N=239	2018

Attie2:124	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as a percentage of total insulin per mouse [%] INS_GLU16p7_PA_pct 110741	DO population		both	19-26wks	N=239	2018

Attie2:125	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose (geometric mean) [ng/mL] INS_gm_GLU 110742 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=242	2018

Attie2:128	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl (geometric mean) [ng/mL] INS_gm_GLU3p3_KCl 110745	DO population		both	19-26wks	N=240	2018

Attie2:129	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 (geometric mean) [ng/mL] INS_gm_GLU8p3_GLP1 110746	DO population		both	19-26wks	N=240	2018

Attie2:130	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) (geometric mean) [ng/mL] INS_gm_GLU8p3_AA 110747	DO population		both	19-26wks	N=240	2018

Attie2:131	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid (geometric mean) [ng/mL] INS_gm_GLU16p7_PA 110748	DO population		both	19-26wks	N=240	2018

Attie2:132	Attie2	hormone quantification	high-fat high-sucrose diet	amount of glucagon per islet after diet [ng/mL] GCG_per_islet 110749	DO population		both	19-26wks	N=241	2018

Attie2:133	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] GCG_GLU3p3_KCl 110750	DO population		both	19-26wks	N=182	2018

Attie2:134	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total glucagon per mouse [%] GCG_GLU3p3_KCl_pct 110751	DO population		both	19-26wks	N=182	2018

Attie2:135	Attie2	DXA	high-fat high-sucrose diet	tibia bone mineral density (on isolated bone) after diet [g/cm²] BMD 110752	DO population		both	19-26wks	N=241	2018

Attie2:136	Attie2	organ weights	high-fat high-sucrose diet	heart weight after diet [g] heart_wt 110753	DO population		both	19-26wks	N=194	2018

Attie2:137	Attie2	organ weights	high-fat high-sucrose diet	liver left lobe weight after diet [g] liver_wt_L 110754	DO population		both	19-26wks	N=194	2018

Attie2:138	Attie2	organ weights	high-fat high-sucrose diet	liver weight minus left lobe after diet [g] liver_wt_remain 110755	DO population		both	19-26wks	N=194	2018

Attie2:139	Attie2	organ weights	high-fat high-sucrose diet	liver weight total after diet [g] liver_wt_tot 110756	DO population		both	19-26wks	N=194	2018

Attie2:140	Attie2	organ weights	high-fat high-sucrose diet	gonadal fat pad weight after diet [g] gonadal_wt 110757 left right	DO population		both	19-26wks	N=194	2018

Attie2:142	Attie2	organ weights	high-fat high-sucrose diet	gonadal fat pad weight after diet, total [g] gonadal_wt_tot 110759	DO population		both	19-26wks	N=194	2018

Attie2:143	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid deoxycholate in feces after diet (per mg feces) [nmol/mg] DCA 110760	DO population		both	19-26wks	N=48	2018

Attie2:144	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid alpha-muricholate in feces after diet (per mg feces) [nmol/mg] aMCA 110761	DO population		both	19-26wks	N=48	2018

Attie2:145	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid beta-muricholate in feces after diet (per mg feces) [nmol/mg] bMCA 110762	DO population		both	19-26wks	N=48	2018

Attie2:146	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid cholate in feces after diet (per mg feces) [nmol/mg] CA 110763	DO population		both	19-26wks	N=48	2018

Attie2:147	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid glycolithocholate in feces after diet (per mg feces) [nmol/mg] GLiCA 110764	DO population		both	19-26wks	N=48	2018

Attie2:148	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid glycochenodeoxycholate in feces after diet (per mg feces) [nmol/mg] GChDCA 110765	DO population		both	19-26wks	N=48	2018

Attie2:149	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid glycoursodeoxycholate in feces after diet (per mg feces) [nmol/mg] GUDCA 110766	DO population		both	19-26wks	N=48	2018

Attie2:150	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid glycodeoxycholate in feces after diet (per mg feces) [nmol/mg] GDCA 110767	DO population		both	19-26wks	N=48	2018

Attie2:151	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid glycocholate in feces after diet (per mg feces) [nmol/mg] GCA 110768	DO population		both	19-26wks	N=48	2018

Attie2:152	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid taurolithocholate in feces after diet (per mg feces) [nmol/mg] TLiCA 110769	DO population		both	19-26wks	N=47	2018

Attie2:153	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid taurohyodeoxycholate in feces after diet (per mg feces) [nmol/mg] THDCA 110770	DO population		both	19-26wks	N=48	2018

Attie2:154	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid tauroursodeoxycholate in feces after diet (per mg feces) [nmol/mg] TUDCA 110771	DO population		both	19-26wks	N=48	2018

Attie2:155	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid taurochenodeoxycholate in feces after diet (per mg feces) [nmol/mg] TChDCA 110772	DO population		both	19-26wks	N=48	2018

Attie2:156	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid taurodeoxycholate in feces after diet (per mg feces) [nmol/mg] TDCA 110773	DO population		both	19-26wks	N=48	2018

Attie2:157	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid taurocholate in feces after diet (per mg feces) [nmol/mg] TCA 110774	DO population		both	19-26wks	N=48	2018

Attie2:158	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid tauro-alpha-muricholate in feces after diet (per mg feces) [nmol/mg] TaMCA 110775	DO population		both	19-26wks	N=48	2018

Attie2:159	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid tauro-beta-muricholate in feces after diet (per mg feces) [nmol/mg] TbMCA 110776	DO population		both	19-26wks	N=48	2018

Attie2:160	Attie2	biomarker quantification	high-fat high-sucrose diet	bile acid chenodeoxycholate in feces after diet (per mg feces) [nmol/mg] ChDCA 110777	DO population		both	19-26wks	N=48	2018

Attie2:161	Attie2	biomarker quantification	high-fat high-sucrose diet	total bile acid in feces after diet (per mg feces) [nmol/mg] bile_acid_total 110778	DO population		both	19-26wks	N=48	2018

Chesler4:1	Chesler4	open field test	(none)	distance traveled in first 4 min, response to novelty, 20 min test [cm] OF_distance_first4 47001	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:2	Chesler4	open field test	(none)	total distance traveled, 20 min test [cm] OF_distance 47002	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:3	Chesler4	open field test	(none)	percentage of time in corners, 20 min test [%] OF_corner_pct 47003	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:4	Chesler4	open field test	(none)	percentage of time in periphery, 20 min test [%] OF_periphery_pct 47004	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:5	Chesler4	open field test	(none)	percentage of time immobile, 20 min test [%] OF_immobile_pct 47005	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:6	Chesler4	open field test	(none)	percentage of time in center, 20 min test [%] OF_center_pct 47006	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:7	Chesler4	light-dark box	(none)	distance traveled in light compartment, 20 min test [cm] LD_distance_light 47007	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:8	Chesler4	light-dark box	(none)	number of light-dark transitions, 20 min test [n] LD_transitions 47008	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:9	Chesler4	light-dark box	(none)	time in light compartment first 4 min, response to novelty, 20 min test [s] LD_light_first4 47009	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:10	Chesler4	light-dark box	(none)	percentage of time in light compartment, 20 min test [%] LD_light_pct 47010	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:11	Chesler4	visual cliff	(none)	distance traveled in top during first 4 min, response to novelty, 20 min test [cm] VC_top_distance_first4 47011	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:12	Chesler4	visual cliff	(none)	time in top during first 4 min, response to novelty, 20 min test [s] VC_top_time_first4 47012	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:13	Chesler4	visual cliff	(none)	total distance traveled in top, 20 min test [cm] VC_top_distance 47013	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:14	Chesler4	visual cliff	(none)	percentage of time in top, 20 min test [%] VC_top_time_pct 47014	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:15	Chesler4	visual cliff	(none)	mean velocity in top, 20 min test [cm/s] VC_top_velocity 47015	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:16	Chesler4	visual cliff	(none)	distance traveled in bottom during first 4 min (response to novelty), 20 min test [cm] VC_bottom_distance_first4 47016	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:17	Chesler4	visual cliff	(none)	time in bottom during first 4 min, response to novelty, 20 min test [s] VC_bottom_time_first4 47017	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:18	Chesler4	visual cliff	(none)	total distance traveled in bottom, 20 min test [cm] VC_bottom_distance 47018	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:20	Chesler4	visual cliff	(none)	percentage of time in bottom, 20 min test [%] VC_bottom_time_pct 47020	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:21	Chesler4	visual cliff	(none)	mean velocity in bottom, 20 min test [cm/s] VC_bottom_velocity 47021	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:22	Chesler4	visual cliff	(none)	number of top to bottom transitions, 20 min test [n] VC_bottom_transitions 47022	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:24	Chesler4	nociception assay	(none)	latency of hindpaw withdrawal, 55°C heat stimulation [s] HP_latency 47024	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:26	Chesler4	tail suspension test	(none)	average frequency climbing, 5 min test [n] TS_frequency_climbing 47026	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:27	Chesler4	tail suspension test	(none)	average time immobile, 5 min test [s] TS_time_immobile 47027	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:28	Chesler4	tail suspension test	(none)	average latency to first immobility episode, 5 min test [s] TS_latency_immobile 47028	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:29	Chesler4	body weight	(none)	body weight at dissection [g] bw 47029	DO population w/par	9	both	12-16wks	N=8	2013

CSNA03:6	CSNA03	open field test	(none)	distance traveled in perimeter and corners, 60 min test (OFT), DO [cm] dist_perimeter_corners_OFT_do 90006	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:9	CSNA03	open field test	(none)	distance traveled in perimeter, 60 min test (OFT), DO [cm] dist_perimeter_OFT_do 90009	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:12	CSNA03	open field test	(none)	distance traveled in corners, 60 min test (OFT), DO [cm] dist_corners_OFT_do 90012	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:15	CSNA03	open field test	(none)	percentage of total distance traveled in center, 60 min test (OFT), DO [%] pct_dist_center_OFT_do 90015	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:18	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), DO dist_slope_OFT_do 90018	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:43	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), DO [cm] amb_dist_OFT_do 90021 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:102	CSNA03	open field test	(none)	time in perimeter and corners, 60 min test (OFT), DO [s] time_perimeter_corners_OFT_do 90102	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:105	CSNA03	open field test	(none)	time in perimeter, 60 min test (OFT), DO [s] time_perimeter_OFT_do 90105	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:108	CSNA03	open field test	(none)	time in corners, 60 min test (OFT), DO [s] time_corner_OFT_do 90108	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:111	CSNA03	open field test	(none)	percentage of total time spent in center, 60 min test (OFT), DO [%] pct_center_time_OFT_do 90111	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:114	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter and corners, 60 min test (OFT), DO [%] pct_dist_perimeter_corners_OFT_do 90114	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:117	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter, 60 min test (OFT), DO [%] pct_dist_perimeter_OFT_do 90117	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:120	CSNA03	open field test	(none)	percentage of total time spent in perimeter and corners, 60 min test (OFT), DO [%] pct_time_perimeter_corner_OFT_do 90120	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:123	CSNA03	open field test	(none)	percentage of total time spent in perimeter, 60 min test (OFT), DO [%] pct_time_perimeter_OFT_do 90123	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:132	CSNA03	light-dark box	(none)	total distance traveled, 20 min test (LD box), DO [cm] dist_LD_do 90132	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:135	CSNA03	light-dark box	(none)	distance traveled in light, 20 min test (LD box), DO [cm] dist_light_LD_do 90135	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:138	CSNA03	light-dark box	(none)	distance traveled in dark, 20 min test (LD box), DO [cm] dist_dark_LD_do 90138	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:141	CSNA03	light-dark box	(none)	percentage of total distance traveled in light, 20 min test (LD box), DO [%] pct_dist_light_LD_do 90141	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:144	CSNA03	light-dark box	(none)	total ambulatory time, 20 min test (LD box), DO [s] amb_time_tot_LD_do 90144	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:147	CSNA03	light-dark box	(none)	ambulatory time in light, 20 min test (LD box), DO [s] amb_time_light_LD_do 90147	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:150	CSNA03	light-dark box	(none)	ambulatory time in dark, 20 min test (LD box), DO [s] amb_time_dark_LD_do 90150	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:153	CSNA03	light-dark box	(none)	percentage of time spent ambulatory in light, 20 min test (LD box), DO [%] pct_amb_time_light_LD_do 90153	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:165	CSNA03	light-dark box	(none)	percentage of time resting in light, 20 min test (LD box), DO [%] pct_rest_time_light_LD_do 90165	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:204	CSNA03	light-dark box	(none)	total time, 20 min test (LD box), DO [s] time_tot_LD_do 90204	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:210	CSNA03	light-dark box	(none)	time in dark, 20 min test (LD box), DO [s] time_dark_LD_do 90210	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:213	CSNA03	light-dark box	(none)	percentage of time in light, 20 min test (LD box), DO [%] pct_time_light_LD_do 90213	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:216	CSNA03	light-dark box	(none)	total ambulatory counts, 20 min test (LD box), DO [n] amb_counts_tot_LD_do 90216	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:219	CSNA03	light-dark box	(none)	ambulatory counts in light, 20 min test (LD box), DO [n] amb_counts_light_LD_do 90219	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:222	CSNA03	light-dark box	(none)	ambulatory counts in dark, 20 min test (LD box), DO [n] amb_counts_dark_LD_do 90222	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:225	CSNA03	light-dark box	(none)	percentage of ambulatory counts in light, 20 min test (LD box), DO [%] pct_amb_counts_light_LD_do 90225	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:264	CSNA03	light-dark box	(none)	total number of light-dark transitions, 20 min test (LD box), DO [n] light_dark_transitions_LD_do 90264	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:267	CSNA03	hole board test	(none)	total number of entries (hole board), DO [n] entries_total_HB_do 90267	DO population w/par	9	both	4-25wks	N=193	2018

CSNA03:270	CSNA03	hole board test	(none)	number of novel entries (hole board), DO [n] entries_novel_HB_do 90270	DO population w/par	9	both	4-25wks	N=193	2018

CSNA03:273	CSNA03	hole board test	(none)	number of repeat entries (hole board), DO [n] entries_repeat_HB_do 90273	DO population w/par	9	both	4-25wks	N=193	2018

CSNA03:288	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, excluding center gray zone (novelty preference), DO [%] time_wo_gray_do 90288	DO population w/par	9	both	8-25wks	N=190	2018

CSNA03:291	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, including center gray zone (novelty preference), DO [%] time_w_gray_do 90291	DO population w/par	9	both	8-25wks	N=190	2018

CSNA03:306	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, DO [cm] dist_d3_d2_cont_do 90306	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:309	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d3_d2_cocaine_do 90309	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:312	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, DO [cm] dist_d5_d3_cont_do 90312	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:315	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, DO [cm] dist_d5_d3_cocaine_do 90315	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:318	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, DO [cm] dist_d12_d2_cont_do 90318	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:321	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d12_d2_cocaine_do 90321	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:324	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, DO [cm] dist_d19_d11_cont_do 90324	DO population w/par	9	both	8-21wks	N=22	2018

CSNA03:327	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, DO [cm] dist_d19_d11_cocaine_do 90327	DO population w/par	9	both	8-21wks	N=23	2018

CSNA03:330	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, DO dist_d3_d11_auc_cont_do 90439	DO population w/par	9	both	8-21wks	N=21	2018

CSNA03:333	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, DO dist_d3_d11_auc_cocaine_do 90442	DO population w/par	9	both	8-21wks	N=21	2018

CSNA03:352	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, DO [cm] dist_f30_cont_do 90330 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:379	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:406	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:433	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO [cm] dist_l60_cocaine_do 90387 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:447	CSNA03	operant conditioning chamber	(none)	exit reason (intravenous self administration), DO de_exit_reason_do 110259 categorical informational	DO population w/par	9	both	4-25wks	N=73	2018

CSNA03:451	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO [n] acquisition_do 110261	DO population w/par	8	both	4-25wks	N=48	2018

CSNA03:470	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	DO population w/par	9	both	4-25wks	N=73	2018

CSNA03:497	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:524	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:537	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:544	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:551	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:558	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:564	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:568	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853	DO population w/par	9	both		N=28	2021

CSNA03:573	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:579	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:585	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:591	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:597	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:603	CSNA03	operant conditioning chamber	(none)	latency (reversal learning assay), DO latency_do_JAX 110531 informational acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:609	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:615	CSNA03	operant conditioning chamber	(none)	retrieval (reversal learning assay), DO retrieval_do_JAX 110535 informational acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:621	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:627	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:633	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:639	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:645	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

Dickson2:1	Dickson2	open field test	(none)	total distance traveled, 20 min test [cm] OFT_distance 54801	DO population		both	12-16wks	N=48	2015

Dickson2:2	Dickson2	open field test	(none)	time spent in center, 20 min test [s] OFT_center 54802	DO population		both	12-16wks	N=48	2015

Dickson2:11	Dickson2	monitoring system	(none)	percentage of total time spent in chamber with novel wall, 10 min test [%] novel_wall 54811	DO population		both	12-16wks	N=48	2015

Dickson2:21	Dickson2	hole board test	(none)	number of hole pokes, 10 min test [n] hole_pokes 54821	DO population		both	12-16wks	N=46	2015

Dickson2:31	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of infusions (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_infusions_mean 54831	DO population		both	12-16wks	N=35	2015

Dickson2:32	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of responses on the active lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_active_mean 54832	DO population		both	12-16wks	N=35	2015

Dickson2:33	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of responses on the inactive lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_inactive_mean 54833	DO population		both	12-16wks	N=35	2015

Dickson2:41	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, breakpoint for infusions (progressive ratio (PR) schedule), one 6h test [n] PR_infusions_breakpoint 54841	DO population		both	12-16wks	N=31	2015

Dickson2:42	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, number of presses on the active lever (progressive ratio (PR) schedule), one 6h test [n] PR_active 54842	DO population		both	12-16wks	N=31	2015

Dickson2:43	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, number of presses on the inactive lever (progressive ratio (PR) schedule), one 6h test [n] PR_inactive 54843	DO population		both	12-16wks	N=31	2015

Gatti2:1	Gatti2	complete blood count	(none)	white blood cell counts [thousands/µL] WBC 28901	DO population		both	10-12wks	N=371	2014

Gatti2:2	Gatti2	complete blood count	(none)	neutrophil counts [n/µL] NEUR 28902	DO population		both	10-12wks	N=371	2014

Hallgrimsson1:1	Hallgrimsson1	None	(none)	DO source [n] do_source 110547 categorical informational	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:2	Hallgrimsson1	None	(none)	DO generation [n] generation 110548 categorical informational	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:3	Hallgrimsson1	None	(none)	age(days) [n] age_days 110549 informational	DO population		both	8-60 wks	N=566	2020

Hallgrimsson1:4	Hallgrimsson1	body weight	(none)	body weight [g] bw 110550	DO population		both	8-60wks	N=569	2020

Hallgrimsson1:5	Hallgrimsson1	bone dimensions	(none)	square root of the summed squared distance of each 3D landmark from the mean landmark position (centroid) of that specimen centroid 110551	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:6	Hallgrimsson1	bone dimensions	(none)	midline superior incisor, right side, x coordinate [mm] lm1_x 110552	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:7	Hallgrimsson1	bone dimensions	(none)	midline superior incisor, right side, y coordinate [mm] lm1_y 110553	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:8	Hallgrimsson1	bone dimensions	(none)	midline superior incisor, right side, z coordinate [mm] lm1_z 110554	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:9	Hallgrimsson1	bone dimensions	(none)	anterior most intersection of nasal and premaxilla, right side, x coordinate [mm] lm2_x 110555	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:10	Hallgrimsson1	bone dimensions	(none)	anterior most intersection of nasal and premaxilla, right side, y coordinate [mm] lm2_y 110556	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:11	Hallgrimsson1	bone dimensions	(none)	anterior most intersection of nasal and premaxilla, right side, z coordinate [mm] lm2_z 110557	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:12	Hallgrimsson1	bone dimensions	(none)	anterior margin of incisive foramen, right side, x coordinate [mm] lm3_x 110558	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:13	Hallgrimsson1	bone dimensions	(none)	anterior margin of incisive foramen, right side, y coordinate [mm] lm3_y 110559	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:14	Hallgrimsson1	bone dimensions	(none)	anterior margin of incisive foramen, right side, z coordinate [mm] lm3_z 110560	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:15	Hallgrimsson1	bone dimensions	(none)	medial maxilla-premaxilla junction, right side, x coordinate [mm] lm4_x 110561	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:16	Hallgrimsson1	bone dimensions	(none)	medial maxilla-premaxilla junction, right side, y coordinate [mm] lm4_y 110562	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:17	Hallgrimsson1	bone dimensions	(none)	medial maxilla-premaxilla junction, right side, z coordinate [mm] lm4_z 110563	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:18	Hallgrimsson1	bone dimensions	(none)	posterior incisive foramen, right side, x coordinate [mm] lm5_x 110564	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:19	Hallgrimsson1	bone dimensions	(none)	posterior incisive foramen, right side, y coordinate [mm] lm5_y 110565	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:20	Hallgrimsson1	bone dimensions	(none)	posterior incisive foramen, right side, z coordinate [mm] lm5_z 110566	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:21	Hallgrimsson1	bone dimensions	(none)	anterior superior alveoli, right side, x coordinate [mm] lm6_x 110567	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:22	Hallgrimsson1	bone dimensions	(none)	anterior superior alveoli, right side, y coordinate [mm] lm6_y 110568	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:23	Hallgrimsson1	bone dimensions	(none)	anterior superior alveoli, right side, z coordinate [mm] lm6_z 110569	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:24	Hallgrimsson1	bone dimensions	(none)	posterior superior alveoli, right side, x coordinate [mm] lm7_x 110570	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:25	Hallgrimsson1	bone dimensions	(none)	posterior superior alveoli, right side, y coordinate [mm] lm7_y 110571	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:26	Hallgrimsson1	bone dimensions	(none)	posterior superior alveoli, right side, z coordinate [mm] lm7_z 110572	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:27	Hallgrimsson1	bone dimensions	(none)	intersection of frontal suture with orbital rim, right side, x coordinate [mm] lm8_x 110573	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:28	Hallgrimsson1	bone dimensions	(none)	intersection of frontal suture with orbital rim, right side, y coordinate [mm] lm8_y 110574	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:29	Hallgrimsson1	bone dimensions	(none)	intersection of frontal suture with orbital rim, right side, z coordinate [mm] lm8_z 110575	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:30	Hallgrimsson1	bone dimensions	(none)	anterior inferior zygomatic, right side, x coordinate [mm] lm9_x 110576	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:31	Hallgrimsson1	bone dimensions	(none)	anterior inferior zygomatic, right side, y coordinate [mm] lm9_y 110577	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:32	Hallgrimsson1	bone dimensions	(none)	anterior inferior zygomatic, right side, z coordinate [mm] lm9_z 110578	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:33	Hallgrimsson1	bone dimensions	(none)	lateral point along frontal suture, right side, x coordinate [mm] lm10_x 110579	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:34	Hallgrimsson1	bone dimensions	(none)	lateral point along frontal suture, right side, y coordinate [mm] lm10_y 110580	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:35	Hallgrimsson1	bone dimensions	(none)	lateral point along frontal suture, right side, z coordinate [mm] lm10_z 110581	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:36	Hallgrimsson1	bone dimensions	(none)	nasion, x coordinate [mm] lm11_x 110582	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:37	Hallgrimsson1	bone dimensions	(none)	nasion, y coordinate [mm] lm11_y 110583	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:38	Hallgrimsson1	bone dimensions	(none)	nasion, z coordinate [mm] lm11_z 110584	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:39	Hallgrimsson1	bone dimensions	(none)	midline endocranial point at the intersection of the frontal bones and the anterior most point of the cribriform plate of the ethmoid, generally placed on the frontal bone, x coordinate [mm] lm12_x 110585	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:40	Hallgrimsson1	bone dimensions	(none)	midline endocranial point at the intersection of the frontal bones and the anterior most point of the cribriform plate of the ethmoid, generally placed on the frontal bone, y coordinate [mm] lm12_y 110586	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:41	Hallgrimsson1	None	(none)	midline endocranial point at the intersection of the frontal bones and the anterior most point of the cribriform plate of the ethmoid, generally placed on the frontal bone, z coordinate [mm] lm12_z 110587	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:42	Hallgrimsson1	bone dimensions	(none)	midline superior incisor, left side, x coordinate [mm] lm13_x 110588	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:43	Hallgrimsson1	bone dimensions	(none)	midline superior incisor, left side, y coordinate [mm] lm13_y 110589	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:44	Hallgrimsson1	bone dimensions	(none)	midline superior incisor, left side, z coordinate [mm] lm13_z 110590	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:45	Hallgrimsson1	bone dimensions	(none)	anterior most intersection of nasal and premaxilla, left side, x coordinate [mm] lm14_x 110591	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:46	Hallgrimsson1	bone dimensions	(none)	anterior most intersection of nasal and premaxilla, left side, y coordinate [mm] lm14_y 110592	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:47	Hallgrimsson1	bone dimensions	(none)	anterior most intersection of nasal and premaxilla, left side, z coordinate [mm] lm14_z 110593	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:48	Hallgrimsson1	bone dimensions	(none)	anterior margin of incisive foramen, left side, x coordinate [mm] lm15_x 110594	DO population		both	8-60wks	N=574	2020

Hallgrimsson1:49	Hallgrimsson1	bone dimensions	(none)	anterior margin of incisive foramen, left side, y coordinate [mm] lm15_y 110595	DO population		both	8-60wks	N=574	2020

Attie2

None

(none)

JMUS id JMUSid 110618 categorical informational

DO population

both

N=242

2018

Attie2

None

(none)

diet diet 110619 categorical informational

DO population

both

N=250

2018

Attie2

None

(none)

DO generation DO_generation 110620 informational

DO population

both

N=250

2018

Attie2

None

(none)

DO batch1 DO_batch1 110621 informational

DO population

both

N=250

2018

Attie2

None

(none)

DO batch2 DO_batch2 110622 informational

DO population

both

N=250

2018

Attie2

None

(none)

DO batch3 DO_batch3 110623 informational

DO population

both

N=250

2018

Attie2

None

(none)

DO batch4 DO_batch4 110624 informational

DO population

both

N=250

2018

Attie2

None

(none)

DO batch5 DO_batch5 110625 informational

DO population

both

N=250

2018

Attie2

None

(none)

date of birth DOB 110626 categorical informational

DO population

both

N=242

2018

Attie2

None

(none)

date of death DOD 110627 categorical informational

DO population

both

N=194

2018

Attie2

None

(none)

date of oral glucose tolerance test date_oGTT 110628 categorical informational

DO population

both

N=248

2018

Attie2

None

(none)

coat color coat_color 110629 categorical informational

DO population

both

N=250

2018

Attie2

None

(none)

some mice store food in bedding which would incorrectly be interpreted as consumed crumblers 110630 categorical informational

DO population

both

N=8

2018

Attie2

colony observation

high-fat high-sucrose diet

number of days on diet [n] diet_days 110631

DO population

both

4-26wks

N=242

2018

Attie2

body weight

high-fat high-sucrose diet

body weight after diet [g] bw 110632 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (5 more)...

DO population

both

5-26wks

N=250

2018

Attie2

body weight

high-fat high-sucrose diet

change in body weight after diet (compared to wk 1) [g] bw_chg 110654 wk: 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

DO population

both

6-21wks

N=250

2018

Attie2

body weight

high-fat high-sucrose diet

change in body weight after diet (compared to wk 10), wk 17 [g] bw_chg_wk17v10 110670

DO population

both

21wks

N=236

2018

Attie2

intake monitoring

high-fat high-sucrose diet

food consumption after diet [g] food 110671 wk: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (4 more)...

DO population

both

5-25wks

N=250

2018

Attie2

intake monitoring

high-fat high-sucrose diet

food consumption average after diet (1 to 21 wks) [g] food_ave 110692

DO population

both

5-25wks

N=250

2018

Attie2

metabolic panel

high-fat high-sucrose diet

plasma glucose after diet (4h fast) [mg/dL] GLU 110693 wk: 6 10 14 22

DO population

both

10-26wks

N=250

2018

Attie2

hormone quantification

high-fat high-sucrose diet

plasma insulin after diet (4h fast) [ng/mL] INS 110697 wk: 6 10 14 22

DO population

both

10-26wks

N=250

2018

Attie2

lipid profile

high-fat high-sucrose diet

plasma triglyceride after diet (4h fast) [mg/dL] TG 110701 wk: 6 10 14 22

DO population

both

10-26wks

N=250

2018

Attie2

body weight

high-fat high-sucrose diet

body weight at time of oral glucose tolerance test (~14 wks on diet) [g] bw_oGTT 110705

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

glucose level at t=0 after ~14 wks on diet (4h fast) [mg/dL] GLU_0min 110706

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

insulin level at t=0 after ~14 wks on diet (4h fast) [ng/mL] INS_0min 110707

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

HOMA-IR: (glucose x insulin) / 405 at t=0 after ~14 wks on diet (4h fast) HOMA_IR 110708

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

HOMA-B: (360 x insulin) / (glucose minus 63) at t=0 after ~14 wks on diet (4h fast) HOMA_B 110709

DO population

both

18wks

N=246

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

glucose area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] GLU_AUC_tot 110710

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

glucose area under curve (AUC) after ~14 wks on diet after subtraction of glucose at t=0 (4h fast) [AUC] GLU_AUC_adj 110711

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

insulin area under curve (AUC) after ~14 wks on diet without correction for baseline difference (4h fast) [AUC] INS_AUC_tot 110712

DO population

both

18wks

N=248

2018

Attie2

glucose tolerance

high-fat high-sucrose diet

insulin area under curve (AUC) after ~14 wks on diet after subtraction of insulin at t=0 (4h fast) [AUC] INS_AUC_adj 110713

DO population

both

18wks

N=248

2018

Attie2

hormone quantification

high-fat high-sucrose diet

plasma adiponectin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [µg/mL] adiponectin 110714

DO population

both

18wks

N=144

2018

Attie2

hormone quantification

high-fat high-sucrose diet

plasma leptin measured at the time oral glucose tolerance test performed after ~14 wks on diet (4h fast) [ng/mL] leptin 110715

DO population

both

18wks

N=96

2018

Attie2

microscopy

high-fat high-sucrose diet

number of islets harvested per mouse after diet [n] islets 110716

DO population

both

19-26wks

N=242

2018

Attie2

hormone quantification

high-fat high-sucrose diet

amount of insulin per islet after diet [ng/mL] INS_per_islet 110717

DO population

both

19-26wks

N=241

2018

Attie2

hormone quantification

high-fat high-sucrose diet

whole pancreas insulin content after diet (insulin content per islet times number of islets) [ng/mL] INS_per_pancreas 110718

DO population

both

19-26wks

N=241

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to glucose [ng/mL] INS_GLU 110719 3.3 mM 8.3 mM 16.7 mM

DO population

both

19-26wks

N=242

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] INS_GLU3p3_KCl 110722

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 [ng/mL] INS_GLU8p3_GLP1 110723

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) [ng/mL] INS_GLU8p3_AA 110724

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid [ng/mL] INS_GLU16p7_PA 110725

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_fc_G3p3 110726

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose, expressed as fold-change over that observed with 3.3.mM glucose [ratio] INS_GLU16p7_fc_G3p3 110727

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU3p3__KCl_fc_G3p3 110728

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G3p3 110729

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G3p3 110730

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus palmitic acid, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU16p7_PA_fc_G3p3 110731

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G8p3 110732

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G8p3 110733

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as fold-change over that observed with 16.7 mM glucose [ratio] INS_GLU16p7_PA_fc_G16p7 110734

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to glucose, expressed as a percentage of total insulin per mouse [%] INS_pct_GLU 110735 3.3 mM 8.3 mM 16.7 mM

DO population

both

19-26wks

N=241

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total insulin per mouse [%] INS_GLU3p3_KCl_pct 110738

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_GLP1_pct 110739

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_AA_pct 110740

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as a percentage of total insulin per mouse [%] INS_GLU16p7_PA_pct 110741

DO population

both

19-26wks

N=239

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to glucose (geometric mean) [ng/mL] INS_gm_GLU 110742 3.3 mM 8.3 mM 16.7 mM

DO population

both

19-26wks

N=242

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl (geometric mean) [ng/mL] INS_gm_GLU3p3_KCl 110745

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 (geometric mean) [ng/mL] INS_gm_GLU8p3_GLP1 110746

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) (geometric mean) [ng/mL] INS_gm_GLU8p3_AA 110747

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid (geometric mean) [ng/mL] INS_gm_GLU16p7_PA 110748

DO population

both

19-26wks

N=240

2018

Attie2

hormone quantification

high-fat high-sucrose diet

amount of glucagon per islet after diet [ng/mL] GCG_per_islet 110749

DO population

both

19-26wks

N=241

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] GCG_GLU3p3_KCl 110750

DO population

both

19-26wks

N=182

2018

Attie2

hormone quantification

high-fat high-sucrose diet

ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total glucagon per mouse [%] GCG_GLU3p3_KCl_pct 110751

DO population

both

19-26wks

N=182

2018

Attie2

DXA

high-fat high-sucrose diet

tibia bone mineral density (on isolated bone) after diet [g/cm²] BMD 110752

DO population

both

19-26wks

N=241

2018

Attie2

organ weights

high-fat high-sucrose diet

heart weight after diet [g] heart_wt 110753

DO population

both

19-26wks

N=194

2018

Attie2

organ weights

high-fat high-sucrose diet

liver left lobe weight after diet [g] liver_wt_L 110754

DO population

both

19-26wks

N=194

2018

Attie2

organ weights

high-fat high-sucrose diet

liver weight minus left lobe after diet [g] liver_wt_remain 110755

DO population

both

19-26wks

N=194

2018

Attie2

organ weights

high-fat high-sucrose diet

liver weight total after diet [g] liver_wt_tot 110756

DO population

both

19-26wks

N=194

2018

Attie2

organ weights

high-fat high-sucrose diet

gonadal fat pad weight after diet [g] gonadal_wt 110757 left right

DO population

both

19-26wks

N=194

2018

Attie2

organ weights

high-fat high-sucrose diet

gonadal fat pad weight after diet, total [g] gonadal_wt_tot 110759

DO population

both

19-26wks

N=194

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid deoxycholate in feces after diet (per mg feces) [nmol/mg] DCA 110760

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid alpha-muricholate in feces after diet (per mg feces) [nmol/mg] aMCA 110761

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid beta-muricholate in feces after diet (per mg feces) [nmol/mg] bMCA 110762

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid cholate in feces after diet (per mg feces) [nmol/mg] CA 110763

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid glycolithocholate in feces after diet (per mg feces) [nmol/mg] GLiCA 110764

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid glycochenodeoxycholate in feces after diet (per mg feces) [nmol/mg] GChDCA 110765

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid glycoursodeoxycholate in feces after diet (per mg feces) [nmol/mg] GUDCA 110766

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid glycodeoxycholate in feces after diet (per mg feces) [nmol/mg] GDCA 110767

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid glycocholate in feces after diet (per mg feces) [nmol/mg] GCA 110768

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid taurolithocholate in feces after diet (per mg feces) [nmol/mg] TLiCA 110769

DO population

both

19-26wks

N=47

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid taurohyodeoxycholate in feces after diet (per mg feces) [nmol/mg] THDCA 110770

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid tauroursodeoxycholate in feces after diet (per mg feces) [nmol/mg] TUDCA 110771

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid taurochenodeoxycholate in feces after diet (per mg feces) [nmol/mg] TChDCA 110772

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid taurodeoxycholate in feces after diet (per mg feces) [nmol/mg] TDCA 110773

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid taurocholate in feces after diet (per mg feces) [nmol/mg] TCA 110774

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid tauro-alpha-muricholate in feces after diet (per mg feces) [nmol/mg] TaMCA 110775

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid tauro-beta-muricholate in feces after diet (per mg feces) [nmol/mg] TbMCA 110776

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

bile acid chenodeoxycholate in feces after diet (per mg feces) [nmol/mg] ChDCA 110777

DO population

both

19-26wks

N=48

2018

Attie2

biomarker quantification

high-fat high-sucrose diet

total bile acid in feces after diet (per mg feces) [nmol/mg] bile_acid_total 110778

DO population

both

19-26wks

N=48

2018

Chesler4

open field test

(none)

distance traveled in first 4 min, response to novelty, 20 min test [cm] OF_distance_first4 47001

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

total distance traveled, 20 min test [cm] OF_distance 47002

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time in corners, 20 min test [%] OF_corner_pct 47003

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time in periphery, 20 min test [%] OF_periphery_pct 47004

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time immobile, 20 min test [%] OF_immobile_pct 47005

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

open field test

(none)

percentage of time in center, 20 min test [%] OF_center_pct 47006

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

distance traveled in light compartment, 20 min test [cm] LD_distance_light 47007

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

number of light-dark transitions, 20 min test [n] LD_transitions 47008

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

time in light compartment first 4 min, response to novelty, 20 min test [s] LD_light_first4 47009

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

light-dark box

(none)

percentage of time in light compartment, 20 min test [%] LD_light_pct 47010

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

distance traveled in top during first 4 min, response to novelty, 20 min test [cm] VC_top_distance_first4 47011

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

time in top during first 4 min, response to novelty, 20 min test [s] VC_top_time_first4 47012

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

total distance traveled in top, 20 min test [cm] VC_top_distance 47013

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

percentage of time in top, 20 min test [%] VC_top_time_pct 47014

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

mean velocity in top, 20 min test [cm/s] VC_top_velocity 47015

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

distance traveled in bottom during first 4 min (response to novelty), 20 min test [cm] VC_bottom_distance_first4 47016

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

time in bottom during first 4 min, response to novelty, 20 min test [s] VC_bottom_time_first4 47017

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

total distance traveled in bottom, 20 min test [cm] VC_bottom_distance 47018

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

percentage of time in bottom, 20 min test [%] VC_bottom_time_pct 47020

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

mean velocity in bottom, 20 min test [cm/s] VC_bottom_velocity 47021

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

visual cliff

(none)

number of top to bottom transitions, 20 min test [n] VC_bottom_transitions 47022

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

nociception assay

(none)

latency of hindpaw withdrawal, 55°C heat stimulation [s] HP_latency 47024

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average frequency climbing, 5 min test [n] TS_frequency_climbing 47026

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average time immobile, 5 min test [s] TS_time_immobile 47027

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average latency to first immobility episode, 5 min test [s] TS_latency_immobile 47028

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

body weight

(none)

body weight at dissection [g] bw 47029

DO population w/par

9

both

12-16wks

N=8

2013

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), DO [cm] dist_perimeter_corners_OFT_do 90006

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), DO [cm] dist_perimeter_OFT_do 90009

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), DO [cm] dist_corners_OFT_do 90012

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), DO [%] pct_dist_center_OFT_do 90015

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), DO dist_slope_OFT_do 90018

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), DO [cm] amb_dist_OFT_do 90021 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), DO [s] time_perimeter_corners_OFT_do 90102

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), DO [s] time_perimeter_OFT_do 90105

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), DO [s] time_corner_OFT_do 90108

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), DO [%] pct_center_time_OFT_do 90111

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), DO [%] pct_dist_perimeter_corners_OFT_do 90114

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), DO [%] pct_dist_perimeter_OFT_do 90117

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), DO [%] pct_time_perimeter_corner_OFT_do 90120

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), DO [%] pct_time_perimeter_OFT_do 90123

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), DO [cm] dist_LD_do 90132

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), DO [cm] dist_light_LD_do 90135

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), DO [cm] dist_dark_LD_do 90138

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), DO [%] pct_dist_light_LD_do 90141

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), DO [s] amb_time_tot_LD_do 90144

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), DO [s] amb_time_light_LD_do 90147

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), DO [s] amb_time_dark_LD_do 90150

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), DO [%] pct_amb_time_light_LD_do 90153

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), DO [%] pct_rest_time_light_LD_do 90165

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), DO [s] time_tot_LD_do 90204

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), DO [s] time_dark_LD_do 90210

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), DO [%] pct_time_light_LD_do 90213

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), DO [n] amb_counts_tot_LD_do 90216

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), DO [n] amb_counts_light_LD_do 90219

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), DO [n] amb_counts_dark_LD_do 90222

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), DO [%] pct_amb_counts_light_LD_do 90225

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), DO [n] light_dark_transitions_LD_do 90264

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

hole board test

(none)

total number of entries (hole board), DO [n] entries_total_HB_do 90267

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), DO [n] entries_novel_HB_do 90270

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), DO [n] entries_repeat_HB_do 90273

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), DO [%] time_wo_gray_do 90288

DO population w/par

9

both

8-25wks

N=190

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), DO [%] time_w_gray_do 90291

DO population w/par

9

both

8-25wks

N=190

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, DO [cm] dist_d3_d2_cont_do 90306

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d3_d2_cocaine_do 90309

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, DO [cm] dist_d5_d3_cont_do 90312

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, DO [cm] dist_d5_d3_cocaine_do 90315

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, DO [cm] dist_d12_d2_cont_do 90318

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d12_d2_cocaine_do 90321

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, DO [cm] dist_d19_d11_cont_do 90324

DO population w/par

9

both

8-21wks

N=22

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, DO [cm] dist_d19_d11_cocaine_do 90327

DO population w/par

9

both

8-21wks

N=23

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, DO dist_d3_d11_auc_cont_do 90439

DO population w/par

9

both

8-21wks

N=21

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, DO dist_d3_d11_auc_cocaine_do 90442

DO population w/par

9

both

8-21wks

N=21

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, DO [cm] dist_f30_cont_do 90330 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO [cm] dist_l60_cocaine_do 90387 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

operant conditioning chamber

(none)

exit reason (intravenous self administration), DO de_exit_reason_do 110259 categorical informational

DO population w/par

9

both

4-25wks

N=73

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO [n] acquisition_do 110261

DO population w/par

8

both

4-25wks

N=48

2018

CSNA03

operant conditioning chamber

cocaine

dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

DO population w/par

9

both

4-25wks

N=73

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853

DO population w/par

9

both

N=28

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

latency (reversal learning assay), DO latency_do_JAX 110531 informational acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

retrieval (reversal learning assay), DO retrieval_do_JAX 110535 informational acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

Dickson2

open field test

(none)

total distance traveled, 20 min test [cm] OFT_distance 54801

DO population

both

12-16wks

N=48

2015

Dickson2

open field test

(none)

time spent in center, 20 min test [s] OFT_center 54802

DO population

both

12-16wks

N=48

2015

Dickson2

monitoring system

(none)

percentage of total time spent in chamber with novel wall, 10 min test [%] novel_wall 54811

DO population

both

12-16wks

N=48

2015

Dickson2

hole board test

(none)

number of hole pokes, 10 min test [n] hole_pokes 54821

DO population

both

12-16wks

N=46

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, mean number of infusions (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_infusions_mean 54831

DO population

both

12-16wks

N=35

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, mean number of responses on the active lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_active_mean 54832

DO population

both

12-16wks

N=35

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, mean number of responses on the inactive lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_inactive_mean 54833

DO population

both

12-16wks

N=35

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, breakpoint for infusions (progressive ratio (PR) schedule), one 6h test [n] PR_infusions_breakpoint 54841

DO population

both

12-16wks

N=31

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, number of presses on the active lever (progressive ratio (PR) schedule), one 6h test [n] PR_active 54842

DO population

both

12-16wks

N=31

2015

Dickson2

operant conditioning chamber

cocaine

intravenous self-administration, number of presses on the inactive lever (progressive ratio (PR) schedule), one 6h test [n] PR_inactive 54843

DO population

both

12-16wks

N=31

2015

Gatti2

complete blood count

(none)

white blood cell counts [thousands/µL] WBC 28901

DO population

both

10-12wks

N=371

2014

Gatti2

complete blood count

(none)

neutrophil counts [n/µL] NEUR 28902

DO population

both

10-12wks

N=371

2014

Hallgrimsson1

None

(none)

DO source [n] do_source 110547 categorical informational

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

None

(none)

DO generation [n] generation 110548 categorical informational

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

None

(none)

age(days) [n] age_days 110549 informational

DO population

both

8-60 wks

N=566

2020

Hallgrimsson1

body weight

(none)

body weight [g] bw 110550

DO population

both

8-60wks

N=569

2020

Hallgrimsson1

bone dimensions

(none)

square root of the summed squared distance of each 3D landmark from the mean landmark position (centroid) of that specimen centroid 110551

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline superior incisor, right side, x coordinate [mm] lm1_x 110552

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline superior incisor, right side, y coordinate [mm] lm1_y 110553

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline superior incisor, right side, z coordinate [mm] lm1_z 110554

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior most intersection of nasal and premaxilla, right side, x coordinate [mm] lm2_x 110555

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior most intersection of nasal and premaxilla, right side, y coordinate [mm] lm2_y 110556

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior most intersection of nasal and premaxilla, right side, z coordinate [mm] lm2_z 110557

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior margin of incisive foramen, right side, x coordinate [mm] lm3_x 110558

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior margin of incisive foramen, right side, y coordinate [mm] lm3_y 110559

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior margin of incisive foramen, right side, z coordinate [mm] lm3_z 110560

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

medial maxilla-premaxilla junction, right side, x coordinate [mm] lm4_x 110561

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

medial maxilla-premaxilla junction, right side, y coordinate [mm] lm4_y 110562

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

medial maxilla-premaxilla junction, right side, z coordinate [mm] lm4_z 110563

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior incisive foramen, right side, x coordinate [mm] lm5_x 110564

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior incisive foramen, right side, y coordinate [mm] lm5_y 110565

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior incisive foramen, right side, z coordinate [mm] lm5_z 110566

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior superior alveoli, right side, x coordinate [mm] lm6_x 110567

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior superior alveoli, right side, y coordinate [mm] lm6_y 110568

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior superior alveoli, right side, z coordinate [mm] lm6_z 110569

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior superior alveoli, right side, x coordinate [mm] lm7_x 110570

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior superior alveoli, right side, y coordinate [mm] lm7_y 110571

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior superior alveoli, right side, z coordinate [mm] lm7_z 110572

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

intersection of frontal suture with orbital rim, right side, x coordinate [mm] lm8_x 110573

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

intersection of frontal suture with orbital rim, right side, y coordinate [mm] lm8_y 110574

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

intersection of frontal suture with orbital rim, right side, z coordinate [mm] lm8_z 110575

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior inferior zygomatic, right side, x coordinate [mm] lm9_x 110576

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior inferior zygomatic, right side, y coordinate [mm] lm9_y 110577

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior inferior zygomatic, right side, z coordinate [mm] lm9_z 110578

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

lateral point along frontal suture, right side, x coordinate [mm] lm10_x 110579

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

lateral point along frontal suture, right side, y coordinate [mm] lm10_y 110580

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

lateral point along frontal suture, right side, z coordinate [mm] lm10_z 110581

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

nasion, x coordinate [mm] lm11_x 110582

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

nasion, y coordinate [mm] lm11_y 110583

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

nasion, z coordinate [mm] lm11_z 110584

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline endocranial point at the intersection of the frontal bones and the anterior most point of the cribriform plate of the ethmoid, generally placed on the frontal bone, x coordinate [mm] lm12_x 110585

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline endocranial point at the intersection of the frontal bones and the anterior most point of the cribriform plate of the ethmoid, generally placed on the frontal bone, y coordinate [mm] lm12_y 110586

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

None

(none)

midline endocranial point at the intersection of the frontal bones and the anterior most point of the cribriform plate of the ethmoid, generally placed on the frontal bone, z coordinate [mm] lm12_z 110587

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline superior incisor, left side, x coordinate [mm] lm13_x 110588

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline superior incisor, left side, y coordinate [mm] lm13_y 110589

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

midline superior incisor, left side, z coordinate [mm] lm13_z 110590

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior most intersection of nasal and premaxilla, left side, x coordinate [mm] lm14_x 110591

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior most intersection of nasal and premaxilla, left side, y coordinate [mm] lm14_y 110592

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior most intersection of nasal and premaxilla, left side, z coordinate [mm] lm14_z 110593

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior margin of incisive foramen, left side, x coordinate [mm] lm15_x 110594

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior margin of incisive foramen, left side, y coordinate [mm] lm15_y 110595

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior margin of incisive foramen, left side, z coordinate [mm] lm15_z 110596

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

medial maxilla-premaxilla junction, left side, x coordinate [mm] lm16_x 110597

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

medial maxilla-premaxilla junction, left side, y coordinate [mm] lm16_y 110598

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

medial maxilla-premaxilla junction, left side, z coordinate [mm] lm16_z 110599

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior incisive foramen, left side, x coordinate [mm] lm17_x 110600

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior incisive foramen, left side, y coordinate [mm] lm17_y 110601

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior incisive foramen, left side, z coordinate [mm] lm17_z 110602

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior superior alveoli, left side, x coordinate [mm] lm18_x 110603

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior superior alveoli, left side, y coordinate [mm] lm18_y 110604

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior superior alveoli, left side, z coordinate [mm] lm18_z 110605

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior superior alveoli, left side, x coordinate [mm] lm19_x 110606

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior superior alveoli, left side, y coordinate [mm] lm19_y 110607

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

posterior superior alveoli, left side, z coordinate [mm] lm19_z 110608

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

intersection of frontal suture with orbital rim, left side, x coordinate [mm] lm20_x 110609

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

intersection of frontal suture with orbital rim, left side, y coordinate [mm] lm20_y 110610

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

intersection of frontal suture with orbital rim, left side, z coordinate [mm] lm20_z 110611

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior inferior zygomatic, left side, x coordinate [mm] lm21_x 110612

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior inferior zygomatic, left side, y coordinate [mm] lm21_y 110613

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

anterior inferior zygomatic, left side, z coordinate [mm] lm21_z 110614

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

lateral point along frontal suture, left side, x coordinate [mm] lm22_x 110615

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

lateral point along frontal suture, left side, y coordinate [mm] lm22_y 110616

DO population

both

8-60wks

N=574

2020

Hallgrimsson1

bone dimensions

(none)

lateral point along frontal suture, left side, z coordinate [mm] lm22_z 110617

DO population

both

8-60wks

N=574

2020

Recla1

nociception assay

(none)

time to respond to heat [s] latency_to_respond 28501

DO population

both

13-17wks

N=130

2013

Recla2

nociception assay

(none)

wound licking or biting 11-60 min after formalin injection (chronic response) [score] formalin_score 62701

DO population

both

13-17wks

N=138

2018

Recla2

nociception assay

(none)

wound licking or biting 11-60 min after formalin injection (chronic response), square root [sqrt(score)] formalin_score_sqrt 62702

DO population

both

13-17wks

N=138

2018

Shorter8

body weight

(none)

body weight [g] bw 110156

DO population

m

12-15wks

N=151

2019

Shorter8

organ weights

(none)

kidney weight, right [g] kidney_wt 110157

DO population

m

12-15wks

N=147

2019

Shorter8

organ weights

(none)

testis weight [g] testis 110158 left right

DO population

m

12-15wks

N=150

2019

Shorter8

organ weights

(none)

testis weight mean [g] testis_mean 110160

DO population

m

12-15wks

N=150

2019

Shorter8

organ weights

(none)

testis weight as percentage of body weight [%] testis_pct_bw 110161

DO population

m

12-15wks

N=150

2019

Shorter8

organ weights

(none)

epididymis plus vas deferens weight [g] epidid_vd 110162 left right

DO population

m

12-15wks

N=150

2019

Shorter8

organ weights

(none)

epididymis plus vas deferens weight mean [g] epidid_vd_mean 110164

DO population

m

12-15wks

N=150

2019

Shorter8

organ weights

(none)

epididymis plus vas deferens weight as percentage of body weight [%] epidid_vd_pct_bw 110165

DO population

m

12-15wks

N=150

2019

Shorter8

organ weights

(none)

seminal vesicles weight total [g] semin_vesi_tot 110166

DO population

m

12-15wks

N=150

2019

Shorter8

organ weights

(none)

seminal vesicles weight as percentage of body weight [%] semin_vesi_pct_bw 110167

DO population

m

12-15wks

N=150

2019

Shorter8

sperm count

(none)

sperm count per mouse (x10⁶) [n] sperm_count 110168

DO population

m

12-15wks

N=150

2019

Shorter8

sperm count

(none)

sperm count per mg testis weight (x10³) [n] sperm_adj 110169

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 110170

DO population

m

12-15wks

N=150

2019

Shorter8

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] sperm_vigor 110171

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

percentage of motile sperm that are 'progressive' [%] sperm_prog 110172

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 110173

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

percentage of motile sperm that are 'intermediate' [%] sperm_int 110174

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

percentage of motile sperm that are 'slow' [%] sperm_slow 110175

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

percentage of motile sperm that are 'weak' [%] sperm_weak 110176

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

sperm mean path velocity [µm/s] sperm_VAP 110177

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

sperm mean straight line velocity [µm/s] sperm_VSL 110178

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

sperm mean curvilinear velocity [µm/s] sperm_VCL 110179

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 110180

DO population

m

12-15wks

N=149

2019

Shorter8

microscopy

(none)

sperm mean cross beat frequency [Hz] sperm_BCF 110181

DO population

m

12-15wks

N=149

2019

Shorter8

histopathology

(none)

percentage of sperm with normal morphology [%] normal_sperm 110182

DO population

m

12-15wks

N=150

2019

Shorter8

histopathology

(none)

percentage of sperm with abnormal head shape [%] abnormal_head 110183

DO population

m

12-15wks

N=150

2019

Shorter8

histopathology

(none)

percentage of sperm with abnormal tail bending [%] abnormal_tail 110184

DO population

m

12-15wks

N=150

2019

Shorter8

histopathology

(none)

percentage of sperm with broken tails [%] broken_tail 110185

DO population

m

12-15wks

N=150

2019

Xenakis2

None

(none)

date_of_birth date_of_birth 118155 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

coat_color coat_color 118156 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

date_of_arrival date_of_arrival 118157 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

age_at_arrival age_at_arrival 118158 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

date_diet_start date_diet_start 118159 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

date_dissection date_dissection 118160 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

date_1stMRI date_1stMRI 118161 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

date_2ndMRI date_2ndMRI 118162 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

date_3rdMRI date_3rdMRI 118163 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_tm4_date food_tm4_date 118164 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_t0_date food_t0_date 118165 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_t2_date food_t2_date 118166 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_t4_date food_t4_date 118167 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_t8_date food_t8_date 118168 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_t12_date food_t12_date 118169 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_t16_date food_t16_date 118170 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_t20_date food_t20_date 118171 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_t26_date food_t26_date 118172 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_tm4_date water_tm4_date 118173 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_tm2_date water_tm2_date 118174 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_t0_date water_t0_date 118175 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_t1_date water_t1_date 118176 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_t2_date water_t2_date 118177 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_t3_date water_t3_date 118178 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t4_date water_t4_date 118179 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t5_date water_t5_date 118180 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t6_date water_t6_date 118181 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t7_date water_t7_date 118182 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t8_date water_t8_date 118183 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t9_date water_t9_date 118184 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t10_date water_t10_date 118185 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t11_date water_t11_date 118186 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t12_date water_t12_date 118187 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t13_date water_t13_date 118188 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t14_date water_t14_date 118189 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t15_date water_t15_date 118190 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t16_date water_t16_date 118191 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t17_date water_t17_date 118192 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t18_date water_t18_date 118193 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t19_date water_t19_date 118194 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t20_date water_t20_date 118195 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t21_date water_t21_date 118196 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t22_date water_t22_date 118197 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t23_date water_t23_date 118198 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t24_date water_t24_date 118199 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t25_date water_t25_date 118200 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_t26_date water_t26_date 118201 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

urine_tm2_1_date urine_tm2_1_date 118202 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

urine_tm2_2_date urine_tm2_2_date 118203 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

urine_tm2_3_date urine_tm2_3_date 118204 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

urine_t12_1_date urine_t12_1_date 118205 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

urine_t12_2_date urine_t12_2_date 118206 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

urine_t12_3_date urine_t12_3_date 118207 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

urine_t24_1_date urine_t24_1_date 118208 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

urine_t24_2_date urine_t24_2_date 118209 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

urine_t24_3_date urine_t24_3_date 118210 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

fbg_tm1_date fbg_tm1_date 118211 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fbg_t4_date fbg_t4_date 118212 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fbg_t8_date fbg_t8_date 118213 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

fbg_t13_date fbg_t13_date 118214 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

fbg_t16_date fbg_t16_date 118215 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fbg_t20_date fbg_t20_date 118216 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fbg_t25_date fbg_t25_date 118217 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fpi_tm1_date fpi_tm1_date 118218 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fpi_t4_date fpi_t4_date 118219 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fpi_t8_date fpi_t8_date 118220 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

fpi_t13_date fpi_t13_date 118221 categorical informational

DO population

m

N=74

2022

Xenakis2

None

(none)

fpi_t16_date fpi_t16_date 118222 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fpi_t20_date fpi_t20_date 118223 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

fpi_t25_date fpi_t25_date 118224 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

bg15_tm1_date bg15_tm1_date 118225 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

bg15_t13_date bg15_t13_date 118226 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

bg15_t25_date bg15_t25_date 118227 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

pi15_tm1_date pi15_tm1_date 118228 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

pi15_t13_date pi15_t13_date 118229 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

pi15_t25_date pi15_t25_date 118230 categorical informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_post_4wks food_post_4wks 118231 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_pre_0wks food_pre_0wks 118232 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_post_0wks food_post_0wks 118233 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_pre_2wks food_pre_2wks 118234 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_post_2wks food_post_2wks 118235 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

food_pre_4wks food_pre_4wks 118236 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_post_4wks_1 food_post_4wks_1 118237 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_pre_8wks food_pre_8wks 118238 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_post_8wks food_post_8wks 118239 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_pre_12wks food_pre_12wks 118240 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_post_12wks food_post_12wks 118241 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_pre_16wks food_pre_16wks 118242 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_post_16wks food_post_16wks 118243 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_pre_20wks food_pre_20wks 118244 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_post_20wks food_post_20wks 118245 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

food_pre_26wks food_pre_26wks 118246 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_4wks water_post_4wks 118247 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_pre_2wks water_pre_2wks 118248 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_post_2wks water_post_2wks 118249 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_pre_0wks water_pre_0wks 118250 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_post_0wks water_post_0wks 118251 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_pre_1wks water_pre_1wks 118252 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_post_1wks water_post_1wks 118253 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_pre_2wks_1 water_pre_2wks_1 118254 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_post_2wks_1 water_post_2wks_1 118255 informational

DO population

m

N=75

2022

Xenakis2

None

(none)

water_pre_3wks water_pre_3wks 118256 informational

DO population

m

N=73

2022

Xenakis2

None

(none)

water_post_3wks water_post_3wks 118257 informational

DO population

m

N=73

2022

Xenakis2

None

(none)

water_pre_4wks water_pre_4wks 118258 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_4wks_1 water_post_4wks_1 118259 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_5wks water_pre_5wks 118260 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_5wks water_post_5wks 118261 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_6wks water_pre_6wks 118262 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_6wks water_post_6wks 118263 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_7wks water_pre_7wks 118264 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_7wks water_post_7wks 118265 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_8wks water_pre_8wks 118266 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_8wks water_post_8wks 118267 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_9wks water_pre_9wks 118268 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_9wks water_post_9wks 118269 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_10wks water_pre_10wks 118270 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_11wks water_post_11wks 118271 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_11wks water_pre_11wks 118272 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_11wks_1 water_post_11wks_1 118273 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_12wks water_pre_12wks 118274 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_12wks water_post_12wks 118275 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_13wks water_pre_13wks 118276 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_13wks water_post_13wks 118277 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_14wks water_pre_14wks 118278 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_14wks water_post_14wks 118279 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_15wks water_pre_15wks 118280 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_15wks water_post_15wks 118281 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_16wks water_pre_16wks 118282 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_16wks water_post_16wks 118283 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_17wks water_pre_17wks 118284 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_17wks water_post_17wks 118285 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_18wks water_pre_18wks 118286 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_18wks water_post_18wks 118287 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_19wks water_pre_19wks 118288 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_19wks water_post_19wks 118289 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_20wks water_pre_20wks 118290 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_20wks water_post_20wks 118291 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_21wks water_pre_21wks 118292 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_21wks water_post_21wks 118293 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_22wks water_pre_22wks 118294 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_22wks water_post_22wks 118295 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_23wks water_pre_23wks 118296 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_23wks water_post_23wks 118297 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_24wks water_pre_24wks 118298 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_24wks water_post_24wks 118299 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_25wks water_pre_25wks 118300 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_post_25wks water_post_25wks 118301 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_pre_26wks water_pre_26wks 118302 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_2_3_wks water_2_3_wks 118303 informational

DO population

m

N=73

2022

Xenakis2

None

(none)

water_4_5_wks water_4_5_wks 118304 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_6_7_wks water_6_7_wks 118305 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_8_9_wks water_8_9_wks 118306 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_10_11_wks water_10_11_wks 118307 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_12_13_wks water_12_13_wks 118308 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_14_15_wks water_14_15_wks 118309 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_16_17_wks water_16_17_wks 118310 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_18_19_wks water_18_19_wks 118311 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_20_21_wks water_20_21_wks 118312 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_22_23_wks water_22_23_wks 118313 informational

DO population

m

N=74

2022

Xenakis2

None

(none)

water_24_25_wks water_24_25_wks 118314 informational

DO population

m

N=74

2022

Xenakis2

body weight

arsenic

body weight [g] bw 118315 iAs: 4 wks before 0 wks after 2 wks after 4 wks after 8 wks after 16 wks after (3 more)...

DO population

m

4-34wks

N=74

2022

Xenakis2

MRI

arsenic

body weight measured by MRI [g] bw_mri 118324 iAs: 2 wks before 12 wks after 24 wks after

DO population

m

6-32wks

N=74

2022

Xenakis2

intake monitoring

arsenic

food consumption [g] food 118327 iAs: 4 wks before to start start to 2 wks after 2 to 4 wks after 4 to 8 wks after (4 more)...

DO population

m

4-34wks

N=74

2022

Xenakis2

intake monitoring

arsenic

water consumption [g] water 118335 iAs: 4 to 2 wks before 2 wks before to start start to 1 wk after 1 to 2 wks after (12 more)...

DO population

m

4-34wks

N=74

2022

Xenakis2

MRI

arsenic

weight of fat tissue [g] fat_wt 118351 iAs: 2 wks before 12 wks after 24 wks after

DO population

m

6-32wks

N=74

2022

Xenakis2

MRI

arsenic

percent of body mass that is fat [%] fat_pct 118354 iAs: 2 wks before 12 wks before 24 wks after

DO population

m

6-32wks

N=74

2022

Xenakis2

MRI

arsenic

weight of lean tissue [g] lean_wt 118357 iAs: 2 wks before 12 wks after 24 wks after

DO population

m

6-32wks

N=74

2022

Xenakis2

MRI

arsenic

percent of body mass that is lean [%] lean_pct 118360 iAs: 2 wks before 12 wks after 24 wks before

DO population

m

6-32wks

N=74

2022

Xenakis2

urinalysis

arsenic

urine volume, 2 wks before iAs [μL] urine_2wksBef 118363 attempt: 1st 2nd 3rd

DO population

m

6wks

N=45

2022

Xenakis2

urinalysis

arsenic

urine volume, 12 wks after iAs [μL] urine_12wks 118366 attempt: 1st 2nd 3rd

DO population

m

20wks

N=25

2022

Xenakis2

urinalysis

arsenic

urine volume, 24 wks after iAs, 1st attempt [μL] urine_24wks_1st 118369

DO population

m

32wks

N=74

2022

Xenakis2

metabolic panel

arsenic

fasting blood glucose (6h fast) [mg/dL] FBG 118370 iAs: 1 wk before 4 wks after 8 wks after 13 wks after 16 wks after 20 wks after 25 wks after

DO population

m

7-33wks

N=74

2022

Xenakis2

metabolic panel

arsenic

blood glucose, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection [mg/dL] BG15 118377 iAs: 1 wk before 13 wks after 25 wks after

DO population

m

7-33wks

N=74

2022

Xenakis2

hormone quantification

arsenic

fasting plasma insulin (6h fast) [ng/mL] FPI 118380 iAs: 1 wk before 4 wks after 8 wks after 13 wks after 16 wks after 20 wks after 25 wks after

DO population

m

7-33wks

N=71

2022

Xenakis2

hormone quantification

arsenic

plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection [ng/mL] PI15 118387 iAs: 1 wk before 13 wks after 25 wks after

DO population

m

7-33wks

N=72

2022

Xenakis2

hormone quantification

arsenic

fasting plasma insulin (6h fast), coefficient of variation (CV) [%] FPI_CV 118390 iAs: 1wk before 4 wks after 8 wks after 13 wks after 16 wks after 20 wks after 25 wks after

DO population

m

7-33wks

N=73

2022

Xenakis2

hormone quantification

arsenic

plasma insulin, 15 min after intraperitoneal (i.p. 0.2% glucose, 6h fast) injection, coefficient of variation (CV) [%] PI15_CV 118397 iAs: 1wk before 13 wks after 25 wks after

DO population

m

7-33wks

N=72

2022

Xenakis2

metabolite quantification

arsenic

inorganic arsenic (iAs) in liver (ppb), 24 wks after iAs [n] iAs_liver 118400

DO population

m

34wks

N=73

2022

Xenakis2

metabolite quantification

arsenic

monomethyl-arsenic acid (MMA) in liver (ppb), 24 wks after iAs [n] MMA_liver 118401

DO population

m

34wks

N=73

2022

Xenakis2

metabolite quantification

arsenic

dimethyl-arsenic acid (DMA) in liver (ppb), 24 wks after iAs [n] DMA_liver 118402

DO population

m

34wks

N=73

2022

Xenakis2

metabolite quantification

arsenic

percentage of of inorganic arsenic (iAs) in liver, 24 wks after iAs [%] iAs_liver_pct 118403

DO population

m

34wks

N=73

2022

Xenakis2

metabolite quantification

arsenic

percentage of monomethyl-arsenic acid (MMA) in liver, 24 wks after iAs [%] MMA_liver_pct 118404

DO population

m

34wks

N=73

2022

Xenakis2

metabolite quantification

arsenic

percentage of dimethyl-arsenic acid (DMA) in liver, 24 wks after iAs [%] DMA_liver_pct 118405

DO population

m

34wks

N=73

2022

Xenakis2

metabolite quantification

arsenic

inorganic arsenic (iAs) in urine (ppb), 24 wks after iAs [n] iAs_urine 118406

DO population

m

32wks

N=51

2022

Xenakis2

metabolite quantification

arsenic

dimethyl-arsenic acid (DMA) in urine (ppb), 24 wks after iAs [n] DMA_urine 118407

DO population

m

32wks

N=74

2022

Xenakis2

metabolite quantification

arsenic

percentage of inorganic arsenic (iAs) in urine, 24 wks after iAs [%] iAs_urine_pct 118408

DO population

m

32wks

N=74

2022

Xenakis2

metabolite quantification

arsenic

percentage of dimethyl-arsenic acid (DMA) in urine, 24 wks after iAs [%] DMA_urine_pct 118409

DO population

m

32wks

N=74

2022

Filter Table Results